作者: Stefan Golz , Andreas Geerts , Ulf Brüggemeier
DOI:
关键词: Urological Diseases 、 Immunology 、 Hematological Diseases 、 Prostaglandin E2 、 Medicine 、 Pharmacology 、 Cancer 、 G protein-coupled receptor 、 Dermatological diseases
摘要: The invention provides a human prostaglandin E2 EP4 which is associated with the cardiovascular diseases, urological hematological endocrinological dermatological gastroenterological metabolic respiratory diseases and cancer. also assays for identification of compounds useful in treatment or prevention features bind to and/or activate inhibit activity as well pharmaceutical compositions comprising such compounds.